Giant High-Risk Solitary Fibrous Tumor of the Pleura Presenting With Chronic Cough in an Octogenarian: A Case Report and Literature Review
This case report describes an 80-year-old man with a giant, high-risk solitary fibrous tumor of the pleura presenting with chronic cough, who achieved long-term disease-free survival following complete surgical resection, underscoring the diagnostic importance of STAT6 immunohistochemistry and the necessity of prolonged surveillance for high-risk lesions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Inside the human chest, the lungs are wrapped in a thin, smooth lining called the pleura, which acts like a protective sac allowing the organs to slide smoothly during breathing. Occasionally, a rare type of growth can form within this lining. These growths, known as solitary fibrous tumors, are made of connective tissue cells and are distinct from the more common cancers that start in the lung tissue itself. For decades, doctors struggled to tell these tumors apart from other similar-looking masses, often relying on guesswork about whether they were harmless or dangerous. However, a major shift occurred when scientists discovered a specific genetic signature unique to these tumors. This discovery allowed for a precise test that can identify the tumor with certainty, changing how doctors diagnose and manage these rare conditions. While many of these tumors grow slowly and cause no problems, some can become enormous, pressing against the heart, airways, and other vital structures, creating a complex challenge for surgeons who must remove them without causing further harm.
This story begins with an eighty-year-old man who had been dealing with a persistent, productive cough for three years. The cough had gradually worsened, becoming more severe over the last month, and was accompanied by a slight, unintentional loss of weight. When doctors examined him, they found a massive growth in the right side of his chest. A detailed scan revealed a tumor so large it measured twenty-three centimeters across, filling a significant portion of the chest cavity. This giant mass was pushing the esophagus to the side, squashing the main airway leading to the right lung, and pressing against the heart. Despite its intimidating size and the pressure it exerted, the patient did not have the fever or blood in his sputum that often signals a severe infection or a different type of cancer. A small sample taken from the tumor suggested it was a solitary fibrous tumor, but the true nature of the growth would only be revealed after it was removed.
The medical team decided that the only way to help the patient was to remove the entire tumor in one piece. Because the mass was stuck tightly to the lung and the chest wall, the surgeons could not simply peel it away. Instead, they performed a major operation, opening the chest from the side to remove the tumor along with a small wedge of the lung it was attached to and a short segment of a rib. This approach ensured that no part of the tumor was left behind. The surgery was successful, and the patient recovered well, going home just one week later. The removed tumor weighed nearly 1.3 kilograms and was a solid, lumpy mass with some areas of bleeding and dead tissue inside.
When pathologists examined the tumor under a microscope, they confirmed the diagnosis using the modern genetic test that looks for a specific protein called STAT6. This test showed that the tumor was indeed a solitary fibrous tumor. However, the examination also revealed signs that the tumor was aggressive. The cells were crowded together, looked very different from one another, and were dividing rapidly. There were also spots where the tissue had died. Based on a standard system that weighs factors like the patient's age, the size of the tumor, and how quickly the cells were dividing, this tumor was classified as high-risk. In the past, doctors might have simply called such a tumor malignant or benign, but this new system provides a more nuanced view, suggesting that while the tumor was removed completely, it has features that could lead to a return of the disease years later.
What makes this case particularly instructive is the contrast between the dangerous appearance of the tumor and the patient's current health. Despite having a tumor with high-risk features, the man has remained completely free of symptoms and shows no signs of the cancer returning thirty-three months after his surgery. His chronic cough has vanished, and he has returned to his normal life. This outcome highlights that removing the entire tumor is the most critical factor in a patient's recovery, even when the tumor looks threatening under a microscope. It also serves as a reminder that while the risk of the tumor coming back is real, it does not happen immediately for everyone. The patient's story suggests that with precise diagnosis and complete surgical removal, even a giant, high-risk tumor can be managed successfully, though long-term monitoring remains essential to catch any potential return of the disease early.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.